# Allogene Wants to Democratize CAR-T. Bispecific Antibodies Already Did.

- slug: allogene-wants-to-democratize-car-t-bispecific-antibodies-already-did
- date: 2026-04-16
- category: Biotech & Life Sciences

Two approved bispecifics are already delivering what Allogene’s experimental CAR-T hopes to do — without weeks of manufacturing wait. The 2027 readout will determine who wins the lymphoma treatment race.

---